[Management of patients infected by the human immunodeficiency virus (HIV). Report of an expert group].
Delfraissy
Jean-François
JF
D016915:AIDS Vaccines; D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology / Q000469:parasitology / Q000517:prevention & control*; D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control*; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy / Q000517:prevention & control; D018791:CD4 Lymphocyte Count; D003453:Cryptococcosis / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D016903:Drug Monitoring / Q000379:methods / Q000592:standards; D004359:Drug Therapy, Combination; D006566:Herpesviridae Infections / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D019288:Herpesvirus 8, Human; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology; D015270:Mycobacterium avium-intracellulare Infection / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D018579:Patient Selection; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D014123:Toxoplasmosis / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D014611:Vaccination / Q000379:methods* / Q000592:standards
D016915:AIDS Vaccines; D019380:Anti-HIV Agents